564 results on '"Duployez, Nicolas"'
Search Results
2. Clinical impact of genetic alterations including germline DDX41 mutations in MDS/low-blast count AML patients treated with azacitidine-based regimens
3. Germline CHEK2 mutations in patients with myeloid neoplasms
4. Prognostic impact of CEBPA mutational subgroups in adult AML
5. Interactions between eosinophils and IL-5Rα–positive mast cells in nonadvanced systemic mastocytosis
6. Genomic imbalance analysis provides new insight into prognostic factors in adult and pediatric T-ALL
7. Genomic profiling of mycosis fungoides identifies patients at high risk of disease progression
8. Orientation et prise en charge de la leucémie aiguë myéloïde néonatale : recommandations du comité leucémies de la SFCE
9. Suspicion d’anomalie constitutionnelle au diagnostic de leucémie chez l’enfant : mise au point du comité leucémies de la Société française des cancers de l’enfant
10. Midostaurin shapes macroclonal and microclonal evolution of FLT3-mutated acute myeloid leukemia
11. French guidelines for the etiological workup of eosinophilia and the management of hypereosinophilic syndromes
12. Clonal origin and development of high hyperdiploidy in childhood acute lymphoblastic leukaemia
13. Negative Impact of TET2 Mutations on Long-Term Survival After Transcatheter Aortic Valve Replacement
14. Somatic mutational landscape of hereditary hematopoietic malignancies caused by germline variants in RUNX1, GATA2, and DDX41
15. Standardising acute myeloid leukaemia classification systems: a perspective from a panel of international experts
16. LSC17 score complements genetics and measurable residual disease in acute myeloid leukemia: an ALFA study
17. Diagnostic et prise en charge des prédispositions génétiques aux hémopathies malignes
18. European standard clinical practice – Key issues for the medical care of individuals with familial leukemia
19. Conduite à tenir devant une prédisposition génétique aux hémopathies malignes chez un patient candidat à l’allogreffe de cellules souches hématopoïétiques (CSH) : recommandations de la SFGM-TC
20. Prognostic impact of DDX41 germline mutations in intensively treated acute myeloid leukemia patients: an ALFA-FILO study
21. Molecular heterogeneity and measurable residual disease of rare NPM1 mutations in acute myeloid leukemia: a nationwide experience from the GBMHM study group
22. Subclonal acquisition of a BCR::ABL1 fusion in a chronic myelomonocytic leukemia
23. Allogeneic stem cell transplantation as a curative therapeutic approach for VEXAS syndrome: a case report
24. Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
25. Publisher Correction: Frugal alignment-free identification of FLT3-internal tandem duplications with FiLT3r
26. Constitutional and acquired genetic variants in ARID5B in pediatric B‐cell precursor acute lymphoblastic leukemia
27. Cutaneous clonal mature plasmacytoid dendritic cell dermatosis in patients with myeloid neoplasms
28. Early detection of WT1 measurable residual disease identifies high-risk patients, independent of transplantation in AML
29. Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies
30. Hematopoietic differentiation at single-cell resolution in NPM1-mutated AML
31. High frequency of clonal hematopoiesis in Erdheim-Chester disease
32. A personalized approach to guide allogeneic stem cell transplantation in younger adults with acute myeloid leukemia
33. Prognostic impact of CEBPA mutational subgroups in adult AML
34. Du nouveau dans la génétique des leucémies aiguës myéloïdes et syndromes myélodysplasiques : les duplications en tandem du gène UBTF définissent une nouvelle entité clinicobiologique de mauvais pronostic
35. Monitoring molecular changes in the management of myelodysplastic syndromes.
36. Added prognostic value of secondary AML-like gene mutations in ELN intermediate-risk older AML: ALFA-1200 study results
37. Postnatal origin of the chromosomal gains in older patients with high hyperdiploid acute lymphoblastic leukemia
38. Philadelphia chromosome‐positive B‐cell lymphoblastic lymphoma in a child: Case report and literature review
39. Correction to: Functional classification of RUNX1 variants in familial platelet disorder with associated myeloid malignancies
40. Disease escape with the selective loss of the Philadelphia chromosome after tyrosine kinase inhibitor exposure in Ph-positive acute lymphoblastic leukemia
41. Familial myeloid malignancies with germline TET2 mutation
42. Impact of Arsenic Trioxide in the Treatment of Higher Risk Acute Promyelocytic Leukemia
43. Clonal Dynamics of FLT3-ITD Positive Acute Myeloid Leukemia Patients with Relapsed/Refractory Disease Following Intensive Chemotherapy +/- Midostaurin
44. Mutational Profile and Dynamics of PPM1D-Mutant Clones in the Spectrum of Myeloid Disorders
45. Impact of Residence in an Agricultural Zone on AML Characteristics
46. Very short insertions in the FLT3 gene are of therapeutic significance in acute myeloid leukemia
47. P-101 Anomalies d’expression d’antigènes RH et hémopathies associées
48. Small myeloid subclones are present at diagnosis of multiple myeloma in patients who develop secondary myelodysplastic syndromes
49. Clonal interference of signaling mutations worsens prognosis in core-binding factor acute myeloid leukemia
50. The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.